Preliminary
Pharmacological — Drugs and compounds that may slow or reverse aging. Rapamycin, metformin, NAD+ …
Review / Commentary
PubMed
Metformin, a cheap diabetes drug, might slow aging, but we need stronger proof before recommending it to everyone.
Metformin activates AMPK and suppresses mTOR/senescence pathways at therapeutic doses; epidemiological consistency is strong, but mechanistic contradictions in aged animal models and lack of definitive human lifespan trials limit causal inference.
This review examines how metformin, a common diabetes drug, may have anti-aging properties by activating cellular stress-response pathways (AMPK), reducing inflammation, and improving mitochondrial function. While observational studies and mechanistic evidence are promising, the authors …
Molecular and cellular endocrinology